Neurovascular Devices Market Is Expected to Reach $3.71 Billion by 2027: Says AMR

Increase in geriatric population across the globe, rise in prevalence of neurovascular diseases, and technological advancements related to neurovascular devices fuel the growth of the global neurovascular devices market. Based on disease pathology, the aneurysm segment held the largest share in 2019. Based on region, on the other hand, Asia-Pacific would register the fastest CAGR of 7.1% throughout the forecast period.


Portland, OR, Sept. 17, 2020 (GLOBE NEWSWIRE) -- According to the report published by Allied Market Research, the global neurovascular devices market was estimated at $2.93 billion in 2019 and is expected to hit $3.71 billion by 2027, registering a CAGR of 5.2% from 2020 to 2027. The report provides a detailed analysis of the top investment pockets, top winning strategies, drivers & opportunities, market size & estimations, competitive landscape, and changing market trends.

Increase in geriatric population across the globe, rise in prevalence of neurovascular diseases, and technological advancements related to neurovascular devices fuel the growth of the global neurovascular devices market. On the other hand, high cost of neurovascular devices and lack of expert neurosurgeons across the globe curtail down the growth to certain extent. However, several opportunities in emerging markets have proven to be highly advantageous for the frontrunners in the sector.

Request Sample Report at: https://www.alliedmarketresearch.com/request-sample/2278

Covid-19 scenario-

  • The outbreak of Covid-19 has led to postponements of several elective surgical procedures which, in turn, has impacted the global neurovascular devices market negatively.
  • At the same time, any surgical process, irrespective of its type and pattern, necessitates certain arrangement to put together proper plan for the surgical treatment. The pandemic has created a turbulence across the world, thus disturbing the growth of the global market.

The global neurovascular devices market is analyzed across product, disease pathology, and region. By product, the embolization devices segment contributed to more than two-fifths of the total market share in 2019 and is anticipated to lead the trail till 2027. The revascularization devices segment, on the other hand, would register the fastest CAGR of 6.9% during the study period.

By disease pathology, the aneurysm segment accounted for nearly half of the total market revenue in 2019 and is expected to rule the roost by the end of 2027. At the same time, the ischemic stroke segment would manifest the fastest CAGR of 7.4% throughout the forecast period.

Byregion, North America held the highest share in 2019, garnering more than one-third of the global neurovascular devices market. At the same time, Asia-Pacific would grow at the fastest CAGR of 7.1% from 2020 to 2027. The other provinces covered in the market report include Europe and LAMEA.

For Purchase Enquiry at: https://www.alliedmarketresearch.com/purchase-enquiry/2278

The key market players analyzed in the global neurovascular devices market report include Stryker Corporation,Johnson & Johnson,   Penumbra, Inc.,Acandis GmbH., Merit Medical Systems, Inc..,W. L. Gore & Associates, Inc., Medtronic Plc,  Microport Scientific Corporation, Terumo Corporation, and Integer Holdings Corporation.These market players have embraced several strategies including partnership, expansion, collaboration, joint ventures, and others to highlight their prowess in the industry.

Avenue Basic Plan | Library Access | 1 Year Subscription |

Sign up for Avenue subscription to access more than 12,000+ company profiles and 2,000+ niche industry market research reports at $699 per month, per seat. For a year, the client needs to purchase minimum 2 seat plan.

Avenue Library Subscription | Request for 14 days free trial of before buying :https://www.alliedmarketresearch.com/avenue/trial/starter

Get more information: https://www.alliedmarketresearch.com/library-access

Similar Reports:

Womens Health Diagnostics Market- Global Opportunities and Industry Forecasts, 2017-2023

 Digital Pathology Market - Global Opportunity Analysis and Industry Forecast, 2018–2026

Disposable Gloves Market - Global Opportunity Analysis and Industry Forecast, 2020–2027

Continuous Glucose Monitoring Systems Market-Global Opportunity Analysis and Industry Forecast, 2020–2027

About Us

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP, based in Portland, Oregon. AMR provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

AMR launched its user-based online library of reports and company profiles, Avenue. An e-access library is accessible from any device, anywhere, and at any time for entrepreneurs, stakeholders, and researchers and students at universities. With reports on more than 60,000 niche markets with data comprising of 600,000 pages along with company profiles on more than 12,000 firms, Avenue offers access to the entire repository of information through subscriptions. A hassle-free solution to clients’ requirements is complemented with analyst support and customization requests.

 

Contact Data